September 11, 2023 Thomas BeethamSeparation Agreement • March 21st, 2024 • Dianthus Therapeutics, Inc. /DE/ • Pharmaceutical preparations
Contract Type FiledMarch 21st, 2024 Company IndustryThe purpose of this letter agreement (“Agreement”) is to confirm the terms of your separation of employment from Magenta Therapeutics, Inc. (“Magenta” or the “Company”).1 The Consideration being offered below is contingent on your agreement to and compliance with the provisions of this Agreement. This Agreement shall be effective on the eighth (8th) day after you sign it (the “Effective Date”), at which time it shall become final and binding on all parties.
September 11, 2023Separation Agreement • November 9th, 2023 • Dianthus Therapeutics, Inc. /DE/ • Pharmaceutical preparations
Contract Type FiledNovember 9th, 2023 Company IndustryThe purpose of this letter agreement (“Agreement”) is to confirm the terms of your separation of employment from Magenta Therapeutics, Inc. (“Magenta” or the “Company”)1. The Consideration being offered below is contingent on your agreement to and compliance with the provisions of this Agreement. This Agreement shall be effective on the eighth (8th) day after you sign it (the “Effective Date”), at which time it shall become final and binding on all parties.